Literature DB >> 7560638

Mast cell number and phenotype in chronic idiopathic urticaria.

C H Smith1, C Kepley, L B Schwartz, T H Lee.   

Abstract

BACKGROUND: Increased levels of histamine have been previously demonstrated in patients with chronic idiopathic urticaria.
OBJECTIVE: The purpose of the study was to determine whether increased numbers of mast cells are present in lesional skin from such patients.
METHODS: Mast cells have been quantified in lesional (n = 11) and nonlesional (n = 9) skin from patients with chronic idiopathic urticaria and compared with site-matched skin from healthy control subjects (n = 10). Mast cells were identified by using a sensitive, double-labeling immunohistochemical technique with specific monoclonal antibodies to mast cell tryptase and chymase and quantified under light microscopy.
RESULTS: No significant differences in mast cell numbers from lesional, nonlesional, or control skin were observed (p > 0.1, Student's t test). In both patients with urticaria and control subjects, more than 99% of cutaneous mast cells contained tryptase and chymase.
CONCLUSIONS: These data indicate that increased skin histamine in chronic idiopathic urticaria is not caused by increased mast cells and may alternatively reflect an increase in histamine content per mast cell, enhanced mast cell activation, or recruitment of basophils into skin in patients with chronic idiopathic urticaria.

Entities:  

Mesh:

Year:  1995        PMID: 7560638     DOI: 10.1016/s0091-6749(95)70055-2

Source DB:  PubMed          Journal:  J Allergy Clin Immunol        ISSN: 0091-6749            Impact factor:   10.793


  25 in total

1.  Chronic urticaria is associated with mast cell infiltration in the gastroduodenal mucosa.

Authors:  Francesca Minnei; Charlotte Wetzels; Gert De Hertogh; Peter Van Eyken; Nadine Ectors; Rossano Ambu; Gavino Faa; Anne Marie Kochuyt; Karel Geboes
Journal:  Virchows Arch       Date:  2005-12-03       Impact factor: 4.064

2.  Corticotropin-releasing hormone induces skin vascular permeability through a neurotensin-dependent process.

Authors:  Jill Donelan; William Boucher; Nikoletta Papadopoulou; Michael Lytinas; Dean Papaliodis; Paul Dobner; Theoharis C Theoharides
Journal:  Proc Natl Acad Sci U S A       Date:  2006-05-08       Impact factor: 11.205

Review 3.  Half-life of IgE in serum and skin: Consequences for anti-IgE therapy in patients with allergic disease.

Authors:  Monica G Lawrence; Judith A Woodfolk; Alexander J Schuyler; Leland C Stillman; Martin D Chapman; Thomas A E Platts-Mills
Journal:  J Allergy Clin Immunol       Date:  2016-07-14       Impact factor: 10.793

Review 4.  Human eosinophils and mast cells: Birds of a feather flock together.

Authors:  Piper A Robida; Pier Giorgio Puzzovio; Hadas Pahima; Francesca Levi-Schaffer; Bruce S Bochner
Journal:  Immunol Rev       Date:  2018-03       Impact factor: 12.988

5.  A Comprehensive Approach to Urticaria: From Clinical Presentation to Modern Biological Treatments Through Pathogenesis.

Authors:  Marco Folci; Giacomo Ramponi; Enrico Brunetta
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

6.  The alpha form of human tryptase is the predominant type present in blood at baseline in normal subjects and is elevated in those with systemic mastocytosis.

Authors:  L B Schwartz; K Sakai; T R Bradford; S Ren; B Zweiman; A S Worobec; D D Metcalfe
Journal:  J Clin Invest       Date:  1995-12       Impact factor: 14.808

Review 7.  Chronic Spontaneous Urticaria: The Devil's Itch.

Authors:  Sarbjit S Saini; Allen P Kaplan
Journal:  J Allergy Clin Immunol Pract       Date:  2018 Jul - Aug

Review 8.  Basophil responsiveness in chronic urticaria.

Authors:  Sarbjit S Saini
Journal:  Curr Allergy Asthma Rep       Date:  2009-07       Impact factor: 4.806

Review 9.  Basophils and skin disorders.

Authors:  Francesco Borriello; Francescopaolo Granata; Gianni Marone
Journal:  J Invest Dermatol       Date:  2014-02-06       Impact factor: 8.551

Review 10.  Current and emerging treatments for chronic spontaneous urticaria.

Authors:  Kirti J Johal; Sarbjit S Saini
Journal:  Ann Allergy Asthma Immunol       Date:  2019-09-05       Impact factor: 6.347

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.